登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Supplementary Table 4 from Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents
Supplementary Table 4 from Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents
收藏
Figshare
2019-07-01 更新
2026-04-28 收录
淋巴瘤治疗机制
高剂量烷化剂
数据链接：
https://figshare.com/articles/dataset/Supplementary_Table_4_from_Mechanisms_of_Lymphoma_Clearance_Induced_by_High-Dose_Alkylating_Agents/22536859
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Supplementary Table 4
补充表（Supplementary Table）4
应用场景：
创建时间：
2019-07-01
相关数据集
Supplementary Table 6 from Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents
淋巴瘤治疗机制
烷化剂药效研究
Supplementary Table 6
aacr.figshare.com
2023-06-21 更新
12
0
Additional file 5 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
淋巴瘤治疗机制
表观遗传重编程
Additional file 5.
Figshare
2024-02-08 更新
3
0
Table S5 from Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma
淋巴瘤治疗机制
基因表达调控
gProfiler results for pathways enriched by ERV-associated genes with significantly upregulated gene expression.
NIAID Data Ecosystem
2
0
Resveratrol Suppresses Constitutive Activation of AKT via Generation of ROS and Induces Apoptosis in Diffuse Large B Cell Lymphoma Cell Lines
淋巴瘤治疗机制
药物诱导凋亡
BackgroundWe have recently shown that deregulation PI3-kinase/AKT survival pathway plays an important role in pathogenesis of diffuse large B cell lymphoma (DLBCL). In an attempt to identify newer the
NIAID Data Ecosystem
3
0
Supplementary Table 3 from Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents
淋巴瘤治疗机制
烷化剂药效研究
Supplementary Table 3
NIAID Data Ecosystem
3
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
